Federal Register: October 28, 2009 (Volume 74, Number 207)
DOCID: fr28oc09-105 FR Doc E9-25906
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
DOCID: fr28oc09-105
SUBJECT CATEGORY:
Importer of Controlled Substances; Notice of Registration
DOCUMENT SUMMARY:
By Notice dated June 22, 2009, and published in the Federal Register on June 29, 2009, (74 FR 31049), Noramco, Inc., Division of OrthoMcNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by letter to the Drug Enforcement Administration (DEA) to be registered as an importer of Tapentadol (9780), a basic class of controlled substance listed in schedule II.
The company plans to import an intermediate of the basic class listed for the bulk manufacture of Tapentadol which it will distribute to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Noramco, Inc. to import the basic class of controlled
substance is consistent with the public interest and with United States
obligations under international treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA has investigated Noramco, Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and
Sec. 958(a), and in accordance with 21 CFR 1301.34, the above named
company is granted registration as an importer of the basic class of controlled substance listed.
Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925906 Filed 102709; 8:45 am]
BILLING CODE 441009P
SUMMARY:
Importer of Controlled Substances; Registrations
DOCUMENT BODY 2:
By Notice dated June 22, 2009, and published in the Federal Register on June 29, 2009, (74 FR 31049), Noramco, Inc., Division of OrthoMcNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by letter to the Drug Enforcement Administration (DEA) to be registered as an importer of Tapentadol (9780), a basic class of controlled substance listed in schedule II.
The company plans to import an intermediate of the basic class listed for the bulk manufacture of Tapentadol which it will distribute to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Noramco, Inc. to import the basic class of controlled
substance is consistent with the public interest and with United States
obligations under international treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA has investigated Noramco, Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and
Sec. 958(a), and in accordance with 21 CFR 1301.34, the above named
company is granted registration as an importer of the basic class of controlled substance listed.
Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925906 Filed 102709; 8:45 am]
BILLING CODE 441009P